EXPERIENCE OF TREATMENT WITH ABATACEPT IN CHILD WITH JUVENILE RHEUMATOID ARTHRITIS AND SECONDARY INEFFICIENCY OF INFLIXIMAB

Opportunities of effective treatment of juvenile arthritis became wide because of introduction of genetically engineered biological drugs to the clinical practice during last years. One of the genetically engineered drugs of first choice for the treatment of refractory types of juvenile arthritis is...

Descripció completa

Dades bibliogràfiques
Autors principals: I.P. Nikishina, V.A. Malievskiy, E.S. Fedorov, E.P. Pervushina, A.Zh. Nuriakhmetova
Format: Article
Idioma:English
Publicat: "Paediatrician" Publishers LLC 2011-05-01
Col·lecció:Вопросы современной педиатрии
Accés en línia:https://vsp.spr-journal.ru/jour/article/view/632